OBJECTIVES: To establish a prescription opioid registry protocol in a large health system and to describe algorithms to characterize individuals using prescription opioids, opioid use episodes, and concurrent use of sedative/hypnotics. STUDY DESIGN: Protocol development and retrospective cohort study. METHODS: Using Kaiser Permanente Northern California (KPNC) electronic health record data, we selected patients using prescription opioids in 2011. Opioid and sedative/hypnotic fills, and physical and psychiatric comorbidity diagnoses, were extracted for years 2008 to 2014. Algorithms were developed to identify each patient's daily opioid and sedative/hypnotic use, and morphine daily-dose equivalent. Opioid episodes were classified as long-term, episodic, or acute. Logistic regression was used to predict characteristics associated with becoming a long-term opioid user. RESULTS: In 2011, 18% of KPNC adult members filled at least 1 opioid prescription. Among those patients, 25% used opioids long term and their average duration of use was more than 4 years. Sedative/hypnotics were used by 76% of long-term users. Being older, white, living in a more deprived neighborhood, having a chronic pain diagnosis, and use of sedative/hypnotics were predictors of initiating long-term opioid use. CONCLUSIONS: This study established a population-based opioid registry that is flexible and can be used to address important questions of prescription opioid use. It will be used in future studies to answer a broad range of other critical public health issues relating to prescription opioid use.
OBJECTIVES: To establish a prescription opioid registry protocol in a large health system and to describe algorithms to characterize individuals using prescription opioids, opioid use episodes, and concurrent use of sedative/hypnotics. STUDY DESIGN: Protocol development and retrospective cohort study. METHODS: Using Kaiser Permanente Northern California (KPNC) electronic health record data, we selected patients using prescription opioids in 2011. Opioid and sedative/hypnotic fills, and physical and psychiatric comorbidity diagnoses, were extracted for years 2008 to 2014. Algorithms were developed to identify each patient's daily opioid and sedative/hypnotic use, and morphine daily-dose equivalent. Opioid episodes were classified as long-term, episodic, or acute. Logistic regression was used to predict characteristics associated with becoming a long-term opioid user. RESULTS: In 2011, 18% of KPNC adult members filled at least 1 opioid prescription. Among those patients, 25% used opioids long term and their average duration of use was more than 4 years. Sedative/hypnotics were used by 76% of long-term users. Being older, white, living in a more deprived neighborhood, having a chronic pain diagnosis, and use of sedative/hypnotics were predictors of initiating long-term opioid use. CONCLUSIONS: This study established a population-based opioid registry that is flexible and can be used to address important questions of prescription opioid use. It will be used in future studies to answer a broad range of other critical public health issues relating to prescription opioid use.
Authors: Laura P Richardson; Joan E Russo; Wayne Katon; Carolyn A McCarty; Andrea DeVries; Mark J Edlund; Bradley C Martin; Mark Sullivan Journal: J Adolesc Health Date: 2012-02-28 Impact factor: 5.012
Authors: Mark J Edlund; Bradley C Martin; Andrea Devries; Ming-Yu Fan; Jennifer Brennan Braden; Mark D Sullivan Journal: Clin J Pain Date: 2010-01 Impact factor: 3.442
Authors: Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner Journal: Clin J Pain Date: 2008 Jul-Aug Impact factor: 3.442
Authors: Constance M Weisner; Cynthia I Campbell; Thomas G Ray; Kathleen Saunders; Joseph O Merrill; Caleb Banta-Green; Mark D Sullivan; Michael J Silverberg; Jennifer R Mertens; Denise Boudreau; Michael Von Korff Journal: Pain Date: 2009-07-05 Impact factor: 6.961
Authors: Pamela J Stoddard; Barbara A Laraia; E Margaret Warton; Howard H Moffet; Nancy E Adler; Dean Schillinger; Andrew J Karter Journal: Diabetes Care Date: 2012-12-28 Impact factor: 19.112
Authors: Ruchir N Karmali; Christopher Bush; Sudha R Raman; Cynthia I Campbell; Asheley C Skinner; Andrew W Roberts Journal: Pharmacoepidemiol Drug Saf Date: 2019-12-18 Impact factor: 2.890
Authors: G Thomas Ray; Andrea Altschuler; Ruchir Karmali; Ingrid Binswanger; Jason M Glanz; Christina L Clarke; Brian Ahmedani; Susan E Andrade; Joseph A Boscarino; Robin E Clark; Irina V Haller; Rulin Hechter; Douglas W Roblin; Katherine Sanchez; Bobbi Jo Yarborough; Steffani R Bailey; Dennis McCarty; Kari A Stephens; Carmen L Rosa; Andrea L Rubinstein; Cynthia I Campbell Journal: JAMIA Open Date: 2022-05-17
Authors: Cynthia I Campbell; Amber L Bahorik; Paul VanVeldhuisen; Constance Weisner; Andrea L Rubinstein; G Thomas Ray Journal: Prev Med Date: 2018-02-02 Impact factor: 4.018
Authors: Bethany L DiPrete; Shabbar I Ranapurwala; Courtney N Maierhofer; Naoko Fulcher; Paul R Chelminski; Christopher L Ringwalt; Timothy J Ives; Nabarun Dasgupta; Vivian F Go; Brian W Pence Journal: JAMA Netw Open Date: 2022-04-01
Authors: Vanessa A Palzes; Constance Weisner; Felicia W Chi; Andrea H Kline-Simon; Derek D Satre; Matthew E Hirschtritt; Murtuza Ghadiali; Stacy Sterling Journal: JMIR Med Inform Date: 2020-07-22
Authors: James Wilton; Younathan Abdia; Mei Chong; Mohammad Ehsanul Karim; Stanley Wong; Aaron MacInnes; Rob Balshaw; Bin Zhao; Tara Gomes; Amanda Yu; Maria Alvarez; Richard C Dart; Mel Krajden; Jane A Buxton; Naveed Z Janjua; Roy Purssell Journal: BMJ Date: 2021-11-18
Authors: Vanessa A Palzes; Mehdi Farokhnia; Andrea H Kline-Simon; Joseph Elson; Stacy Sterling; Lorenzo Leggio; Constance Weisner; Felicia W Chi Journal: Neuropsychopharmacology Date: 2021-08-02 Impact factor: 7.853